Trials / Recruiting
RecruitingNCT07390747
A Trial of SHR-2173 in Healthy Volunteers
A Phase 1, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a Single Subcutaneous Administration of SHR-2173 in Healthy Participants
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Atridia Pty Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic and immunogenicity profile of a single dose of SHR-2173 in healthy participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-2173 Injection/SHR-2173 placebo | Single dose SHR-2173 injection or matching placebo given subcutaneously |
Timeline
- Start date
- 2026-03-06
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
- First posted
- 2026-02-05
- Last updated
- 2026-03-13
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07390747. Inclusion in this directory is not an endorsement.